FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2068783453> ?p ?o ?g. }

• W2068783453 endingPage "820" @default.
• W2068783453 startingPage "812" @default.
• W2068783453 abstract "The Oxford classification of immunoglobulin A (IgA) nephropathy (IgAN) provides a histopathologic grading system that is associated with kidney disease outcomes independent of clinical features. We evaluated the Oxford IgAN classification in a large cohort of patients from China.Retrospective study.1,026 adults with IgAN from 18 referral centers in China. Inclusion criteria and statistical analysis were similar to the Oxford study.Histologic findings of mesangial hypercellularity score, endocapillary proliferation, segmental sclerosis or adhesion, crescents, necrosis, and tubular atrophy/interstitial fibrosis. Clinical features, blood pressure, estimated glomerular filtration rate (eGFR), proteinuria, and treatment modalities.Time to a 50% reduction in eGFR or end-stage renal disease (the combined event); the rate of eGFR decline (slope of eGFR); proteinuria during follow-up.Compared with the Oxford cohort, the Chinese cohort had a lower proportion of patients with mesangial hypercellularity (43%) and endocapillary proliferation (11%), higher proportion with segmental sclerosis or adhesion (83%) and necrosis (15%), and similar proportion with crescents (48%) and tubular atrophy/interstitial fibrosis (moderate, 24%; severe, 3.3%). During a median follow-up of 53 (25th-75th percentile, 36-67) months, 159 (15.5%) patients reached the combined event. Our study showed that patients with a mesangial hypercellularity score higher than 0.5 were associated with a 2.0-fold (95% CI, 1.5-2.8; P<0.001) higher risk of the combined event than patients with a score of 0.5 or lower. Patients with tubular atrophy/interstitial fibrosis of 25%-50% and >50% versus <25% were associated with a 3.7-fold (95% CI, 2.6-5.1; P<0.001) and 15.1-fold (95% CI, 9.5-24.2; P<0.001) higher risk of the combined event, respectively. Endocapillary proliferation, glomerular crescents, and necrosis were not significant.Retrospective study; the therapeutic interventions were miscellaneous.We confirmed the associations of mesangial hypercellularity and tubular atrophy/interstitial fibrosis with kidney disease outcomes." @default.
• W2068783453 created "2016-06-24" @default.
• W2068783453 creator A5000145535 @default.
• W2068783453 creator A5001094449 @default.
• W2068783453 creator A5004463257 @default.
• W2068783453 creator A5006842513 @default.
• W2068783453 creator A5007054845 @default.
• W2068783453 creator A5007255131 @default.
• W2068783453 creator A5009700716 @default.
• W2068783453 creator A5009928424 @default.
• W2068783453 creator A5010297641 @default.
• W2068783453 creator A5012488321 @default.
• W2068783453 creator A5012536776 @default.
• W2068783453 creator A5017164999 @default.
• W2068783453 creator A5018620202 @default.
• W2068783453 creator A5018860616 @default.
• W2068783453 creator A5023236133 @default.
• W2068783453 creator A5027470451 @default.
• W2068783453 creator A5031318134 @default.
• W2068783453 creator A5032454574 @default.
• W2068783453 creator A5034152414 @default.
• W2068783453 creator A5037338561 @default.
• W2068783453 creator A5038079033 @default.
• W2068783453 creator A5039677088 @default.
• W2068783453 creator A5043630267 @default.
• W2068783453 creator A5052713292 @default.
• W2068783453 creator A5055410111 @default.
• W2068783453 creator A5059314686 @default.
• W2068783453 creator A5062253236 @default.
• W2068783453 creator A5062656698 @default.
• W2068783453 creator A5062770849 @default.
• W2068783453 creator A5063718631 @default.
• W2068783453 creator A5064144494 @default.
• W2068783453 creator A5065800913 @default.
• W2068783453 creator A5066221170 @default.
• W2068783453 creator A5070792980 @default.
• W2068783453 creator A5071558684 @default.
• W2068783453 creator A5073235303 @default.
• W2068783453 creator A5076153061 @default.
• W2068783453 creator A5076805460 @default.
• W2068783453 creator A5077423550 @default.
• W2068783453 creator A5082548949 @default.
• W2068783453 creator A5084987057 @default.
• W2068783453 creator A5085249987 @default.
• W2068783453 creator A5085317030 @default.
• W2068783453 creator A5085657697 @default.
• W2068783453 creator A5086161254 @default.
• W2068783453 creator A5086995869 @default.
• W2068783453 date "2012-11-01" @default.
• W2068783453 modified "2023-10-17" @default.
• W2068783453 title "A Multicenter Application and Evaluation of the Oxford Classification of IgA Nephropathy in Adult Chinese Patients" @default.
• W2068783453 cites W1971086200 @default.
• W2068783453 cites W1985193382 @default.
• W2068783453 cites W1991981495 @default.
• W2068783453 cites W1997948783 @default.
• W2068783453 cites W2029854072 @default.
• W2068783453 cites W2034319303 @default.
• W2068783453 cites W2034844805 @default.
• W2068783453 cites W2044471513 @default.
• W2068783453 cites W2045301758 @default.
• W2068783453 cites W2048522842 @default.
• W2068783453 cites W2050337792 @default.
• W2068783453 cites W2055600387 @default.
• W2068783453 cites W2072641675 @default.
• W2068783453 cites W2076364765 @default.
• W2068783453 cites W2088041869 @default.
• W2068783453 cites W2092066827 @default.
• W2068783453 cites W2093339618 @default.
• W2068783453 cites W2105803357 @default.
• W2068783453 cites W2123427818 @default.
• W2068783453 cites W2128331580 @default.
• W2068783453 cites W2128552047 @default.
• W2068783453 cites W2135143233 @default.
• W2068783453 cites W2138161657 @default.
• W2068783453 cites W2151689843 @default.
• W2068783453 cites W2152853007 @default.
• W2068783453 cites W2162989837 @default.
• W2068783453 cites W2164777277 @default.
• W2068783453 cites W2167898282 @default.
• W2068783453 doi "https://doi.org/10.1053/j.ajkd.2012.06.011" @default.
• W2068783453 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22819700" @default.
• W2068783453 hasPublicationYear "2012" @default.
• W2068783453 type Work @default.
• W2068783453 sameAs 2068783453 @default.
• W2068783453 citedByCount "128" @default.
• W2068783453 countsByYear W20687834532012 @default.
• W2068783453 countsByYear W20687834532013 @default.
• W2068783453 countsByYear W20687834532014 @default.
• W2068783453 countsByYear W20687834532015 @default.
• W2068783453 countsByYear W20687834532016 @default.
• W2068783453 countsByYear W20687834532017 @default.
• W2068783453 countsByYear W20687834532018 @default.
• W2068783453 countsByYear W20687834532019 @default.
• W2068783453 countsByYear W20687834532020 @default.
• W2068783453 countsByYear W20687834532021 @default.
• W2068783453 countsByYear W20687834532022 @default.
• W2068783453 countsByYear W20687834532023 @default.
• W2068783453 crossrefType "journal-article" @default.

• next